Cargando…
The role of substance P in depression: therapeutic implications
Substance P (for “powder”), identified as a gut tachykinin in 1931 and involved in the control of multiple other autonomic functions, notably pain transmission, is the focus of intense fundamental and clinical psychiatric research as a central neurotransmitter, neuromodulator, and immunomodulator, a...
Autores principales: | Schwarz, Markus J., Ackenheil, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181667/ https://www.ncbi.nlm.nih.gov/pubmed/22033776 |
Ejemplares similares
-
The therapeutic transnosological use of psychotropic drugs
por: Ackenheil, Manfred, et al.
Publicado: (1999) -
15727 K(ATP) channel prodrugs as therapeutics for chronic pain and substance abuse disorders
por: Doucette, Alexis, et al.
Publicado: (2021) -
Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002) -
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004) -
Increased substance P and synaptic remodeling occur in the trigeminal sensory system with sustained osteoarthritic temporomandibular joint sensitivity
por: Sperry, Megan M., et al.
Publicado: (2021)